Behzadi AH, Zhao Y, Farooq Z, et al. Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis. Radiology. 2017;286:471-82.
Lee Y, Chung TY, Liu HC. A rare case of acute respiratory distress syndrome caused by use of gadolinium‐based magnetic resonance imaging contrast media. Respirol Case Rep. 2019;8:e00483.
Kerget B, Aksakal A, Afsin DE, et al. Acute respiratory distress syndrome after the use of gadolinium contrast agent. Respir Med Case Rep. 2018;25:336-8.
Hunt CH, Harman RP, Hesley GK. Frequency and severity of adverse efects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses. Am J Roentgenol. 2009; 193:1124-7.
Borish L, Matlof SM, Findlay SR. Radiographic contrast media-induced noncardiogenic pulmonary edema: case report and review of the literature. J Allergy Clin Immun. 1984;74:104-7.
Panesar M, Boateng F, Patel SS, et al. Transmetallation and gadolinium: Do low iron stores prevent the development of nephrogenic systemic fibrosis in high‐risk end‐stage renal disease patients? Haemodial Int. 2010;14:289-94.
Forsting M, Palkowitsch P. Prevalence of acute adverse reactions to gadobutrol—a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials. Eur J Radiol. 2010;74:186-92.
Schell-Chaple HM, Puntillo KA, Mathay MA, Liu KD. Body temperature and mortality in patients with acute respiratory distress syndrome. Am J Crit Care. 2015;24: 5-23.